Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.7 SEK | -0.23% | -10.15% | +24.82% |
May. 07 | Vicore Pharma Holding AB Announces Board Appointments | CI |
May. 03 | Vicore Pharma Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 52M 4.88M | Sales 2025 * | 393M 36.87M | Capitalization | 1.98B 185M |
---|---|---|---|---|---|
Net income 2024 * | -236M -22.13M | Net income 2025 * | -173M -16.22M | EV / Sales 2024 * | 30.5 x |
Net cash position 2024 * | 391M 36.69M | Net cash position 2025 * | 210M 19.71M | EV / Sales 2025 * | 4.5 x |
P/E ratio 2024 * |
-10.9
x | P/E ratio 2025 * |
-7.53
x | Employees | 24 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.02% |
Latest transcript on Vicore Pharma Holding AB
1 day | -0.23% | ||
1 week | -10.15% | ||
Current month | -1.99% | ||
1 month | +6.12% | ||
3 months | +27.34% | ||
6 months | +14.94% | ||
Current year | +24.82% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmed Mousa
CEO | Chief Executive Officer | 40 | 23-09-08 |
Hans Jeppsson
DFI | Director of Finance/CFO | - | 16-12-31 |
Elin Rosendahl
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 17-12-31 | |
Chairman | 66 | 17-12-31 | |
Michael Buschle
BRD | Director/Board Member | 64 | 22-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 17.7 | -0.23% | 165,884 |
24-05-23 | 17.74 | -1.99% | 434,685 |
24-05-22 | 18.1 | -4.44% | 441,967 |
24-05-21 | 18.94 | -5.54% | 506,652 |
24-05-20 | 20.05 | +1.78% | 861,599 |
Delayed Quote Nasdaq Stockholm, May 24, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.82% | 186M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- VICO Stock